Discovery Accelerated
GT Apeiron is redefining medical discovery, using artificial intelligence to streamline the drug development process—from target selection to clinical trials. With strategic locations in Shanghai and the San Francisco Bay Area, and significant partnerships in Europe, Apeiron integrates talent and cutting-edge technologies spanning multiple regions. We believe that by pushing the frontiers of biomedical innovation and engaging talent globally we can create breakthrough medicines for the highest unmet medical needs.
Latest News
October 17, 2023
GT Apeiron Announces Development Candidate Nomination of Brain Penetrant PRMT5 Inhibitor, GTA182, for the Potential Treatment of MTAP-Deleted Solid Cancers
San Francisco Bay Area
533 Airport Blvd
Suite 400
Burlingame CA 94010
United States
Tel: +1-408-663-1178
Shanghai
1st Floor, Building C2
No.1976 Middle Gaoke Road
Pudong New District, Shanghai
China
Tel: 021-50541559
Contact
info@apeiron-bio.com